tsRNA: A Promising Biomarker in Breast Cancer

Ting Huang1, Yuexin Zhao2, Guoqin Jiang1

  • 1Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.

Journal of Cancer
|April 5, 2024
PubMed

Insights

tRNA-derived small RNAs (tsRNAs) are key regulators in cellular processes. Their dysregulation is linked to breast cancer development, offering new diagnostic and therapeutic targets.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • tRNA-derived small RNAs (tsRNAs) are emerging non-coding RNAs with critical roles in gene regulation.
  • Dysregulation of tsRNAs is implicated in the pathogenesis of various cancers.
  • Breast cancer, a prevalent malignancy, shows altered tsRNA expression patterns.

Purpose of the Study:

  • To review the generation, classification, and functional mechanisms of tsRNAs.
  • To elucidate the biological effects and underlying mechanisms of tsRNAs in breast cancer.
  • To highlight tsRNAs as potential biomarkers and therapeutic targets for breast cancer.

Main Methods:

  • Literature review of studies on tsRNA generation and function.
  • Analysis of research on tsRNA involvement in breast cancer.
  • Synthesis of current knowledge on tsRNA mechanisms in cancer biology.

Main Results:

  • tsRNAs are generated from tRNA/pre-tRNA and participate in RNA silencing, transcription, and translation.
  • Altered tsRNA profiles are observed in breast cancer, correlating with disease progression.
  • tsRNAs exhibit potential as diagnostic markers and therapeutic targets in breast cancer.

Conclusions:

  • tsRNAs play significant roles in breast cancer pathogenesis.
  • Further research into tsRNAs may offer novel avenues for breast cancer diagnosis and treatment.
  • tsRNAs represent a promising area for future oncology research.